BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6282932)

  • 1. Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets.
    Fujimoto T; Ohara S; Hawiger J
    J Clin Invest; 1982 Jun; 69(6):1212-22. PubMed ID: 6282932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.
    Kao KJ; Pizzo SV; McKee PA
    J Clin Invest; 1979 Apr; 63(4):656-64. PubMed ID: 108291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesive protein expression on thrombin-stimulated platelets: time-dependent modulation of anti-fibrinogen, -fibronectin, and -von Willebrand factor antibody binding.
    Peerschke EI
    Blood; 1992 Feb; 79(4):948-53. PubMed ID: 1737104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.
    Timmons S; Kloczewiak M; Hawiger J
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4935-9. PubMed ID: 6087354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of glycoprotein IIB/IIIA exposure on platelets stimulated with alpha-thrombin.
    van Willigen G; Akkerman JW
    Blood; 1992 Jan; 79(1):82-90. PubMed ID: 1309427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J; Parkinson S; Timmons S
    Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets have more than one binding site for von Willebrand factor.
    Ruggeri ZM; De Marco L; Gatti L; Bader R; Montgomery RR
    J Clin Invest; 1983 Jul; 72(1):1-12. PubMed ID: 6223940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of ristocetin-induced platelet aggregation: binding of factor VIII to platelets.
    Schneider-Trip MD; Jenkins CS; Kahlé LH; Sturk A; ten Cate JW
    Br J Haematol; 1979 Sep; 43(1):99-112. PubMed ID: 508625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-binding of the von Willebrand factor.
    Green D; Muller HP
    Thromb Haemost; 1978 Jun; 39(3):689-94. PubMed ID: 309191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that changes in platelet cyclic AMP levels regulate the fibrinogen receptor on human platelets.
    Graber SE; Hawiger J
    J Biol Chem; 1982 Dec; 257(24):14606-9. PubMed ID: 6294072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
    Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
    J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of von Willebrand factor with human platelets in the plasma milieu.
    Schullek J; Jordan J; Montgomery RR
    J Clin Invest; 1984 Feb; 73(2):421-8. PubMed ID: 6230372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrolysis of human platelet membrane glycoproteins with a Serratia marcescens metalloprotease: effect on response to thrombin and von Willebrand factor.
    Cooper HA; Bennett WP; White GC; Wagner RH
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1433-7. PubMed ID: 7041120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipase abolishes the effect of stimulated platelets on the thrombin activation of factor VIII.
    Rick ME; Krizek DM
    Blood; 1988 Jan; 71(1):173-7. PubMed ID: 3120821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.
    Lombardo VT; Hodson E; Roberts JR; Kunicki TJ; Zimmerman TS; Ruggeri ZM
    J Clin Invest; 1985 Nov; 76(5):1950-8. PubMed ID: 2414325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of thrombin-mediated activation of factor VIII:C by calcium ions, phospholipid, and platelets.
    Hultin MB
    Blood; 1985 Jul; 66(1):53-8. PubMed ID: 3924141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the deaggregation of human and rabbit platelets.
    Kinlough-Rathbone RL; Mustard JF; Perry DW; Dejana E; Cazenave JP; Packham MA; Harfenist EJ
    Thromb Haemost; 1983 Jun; 49(3):162-7. PubMed ID: 6308846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
    J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet receptor desensitization induced by elevated prostacyclin levels causes platelet-endothelial cell adhesion.
    Darius H; Binz C; Veit K; Fisch A; Meyer J
    J Am Coll Cardiol; 1995 Sep; 26(3):800-6. PubMed ID: 7543911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.